EPO: Appeal board of EPO provides guidance on amendments filed late

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

EPO: Appeal board of EPO provides guidance on amendments filed late

In opposition proceedings before the EPO, the formal admissibility of amendments filed late by proprietors is a frequently debated topic and differently decided on. A recent appeal decision, T 500/15, reiterates the criteria for the assessment of admissibility of amendments that are filed late and the specific criteria the competent departments of the EPO should apply when exercising their discretionary powers with regard to admissibility.

Decision T 500/15 concerns an appeal against a first instance decision revoking a European patent. In the first instance opposition proceedings, the patentee had not filed a substantiated reply to the opposition. No amendments or substantiated arguments were submitted by the patentee within the time limit set by the EPO for making written submissions ahead of the oral proceedings. The patentee had, however, eventually filed an amended set of claims as his main request 10 days prior to the oral hearing. Following a debate of only 15 minutes at the oral proceedings, the opposition division had decided not to admit the amended claims into the proceedings and thus to revoke the patent.

The opposition division's reason for not admitting the amended claims was, in particular, that the examination of the amended claims would have required extensive discussions, and that admitting them into the proceedings would have compromised the need for procedural economy.

In the subsequent second instance proceedings, the appeal board entrusted with the matter came to the conclusion in decision T 500/15 that the first instance department had not adequately exercised its discretionary powers with regard to the admissibility of the amended claims. The board of appeal in particular held that the department of first instance had failed to examine the amended claims on their substantive merits. According to the board, procedural aspects, notably the need for procedural economy, are to be considered only in conjunction with a case-specific, substantive examination of the prima facie permissibility of the amended claims. Such substantive assessment had not been conducted by the opposition division. The case is therefore now being remitted back to the department of first instance for further prosecution.

frederiksen.jpg

Jakob Pade Frederiksen

Inspicos P/S

Kogle Allé 2

DK-2970 Hoersholm

Copenhagen, Denmark

Tel: +45 7070 2422

Fax: +45 7070 2423

info@inspicos.com

www.inspicos.com


more from across site and SHARED ros bottom lb

More from across our site

The firm reveals how its litigation strategies informed the arguments that took Masimo’s judgment past $818 million
The firm was rebuilding its IP practice through a string of patent hires and a Texas expansion, but its dissolution has put the newly built talent back into the market
AI can exploit longstanding gaps in copyright protection at remarkable speed, but EU law still provides tools to fight back, says Simon Hembt at Bird & Bird
The firm has tapped a local patent trio to establish a foothold in the market and broaden its national presence
New Asia-Pacific IP head Jonathan Chu is eyeing opportunities arising from Chinese technology licensing, overseas enforcement and increasingly IP-heavy cross-border deals
Europe’s largest intellectual property convention and trade fair is back: IP Service World 2026 takes place in Munich from November 23–25 – the 16th edition, with 1,400-plus attendees from 55-plus nations, 100-plus speakers, and 100-plus exhibitors. Three days. Two focused areas. One IP marketplace.
Mehmet Gün and Uğur Aktekin discuss four decades of change in Türkiye’s legal market, the firm’s commitment to independence and the challenge of building an institution that can outlast its founders
Boehringer Ingelheim has instructed a team from Kirkland, while Teva is being represented by Pinsent Masons
The Delhi High Court’s latest directions offer an opportunity to move beyond remedies against bad-faith registrations and address how suspicious applications are identified in the first place, says Fatima Baig at Lexlinc
Camilla Hamrin describes how the acquisition by Acapo Onsagers will impact Bergenstråhle’s trademark practice – and reflects on changes she has seen over 30 years in IP
Gift this article